Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 4/20 | 0.63 |
| ▸ | MME | P08473 | 4/20 | 0.63 |
| ▸ | CASP3 | P42574 | 2/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | CASP9 | P55211 | 1/20 | 0.62 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.61 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.54 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | TACR1 | P25103 | 2/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6552944 | 1.00 | ECE1 (0.63) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL6552949 | 1.00 | ECE1 (0.63) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL13884433 | 1.00 | ECE1 (0.63) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL13589992 | 1.00 | ECE1 (0.63) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL14778231 | 0.96 | MME (0.63) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL2873941 | 0.96 | MME (0.63) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL13957718 | 0.95 | MME (0.64) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL1426719 | 0.95 | MME (0.64) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL13884435 | 0.95 | MME (0.64) | ECE1MMECASP3CASP1CASP9 | |
| SCHEMBL2181857 | 0.94 | CASP1 (0.62) | ECE1MMECASP3CASP1CASP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116064280-B | Siamese bacillus and application thereof | 大连工业大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-116004423-B | Bacillus bailii and application thereof | 大连工业大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-116064279-B | Siamese bacillus and application thereof in low-salt fermentation of food | 大连工业大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-116004424-B | Bacillus tequilensis and application thereof in low-salt fermentation of food | 大连工业大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-116064279-B | Siamese bacillus and application thereof in low-salt fermentation of food | 大连工业大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-117511770-A | Preparation method of direct-vat starter and application of direct-vat starter in fermentation of stinky mandarin fish | 大连工业大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-116064280-A | Siamese bacillus and application thereof | 大连工业大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-116064279-A | Siamese bacillus and application thereof in low-salt fermentation of food | 大连工业大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-116064279-A | Siamese bacillus and application thereof in low-salt fermentation of food | 大连工业大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-116004424-A | Bacillus tequilensis and application thereof in low-salt fermentation of food | 大连工业大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-116004423-A | Bacillus bailii and application thereof | 大连工业大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-110582562-B | Aspergillus fermentation product, food composition, cosmetic composition, raw material for Aspergillus fermentation product, process for producing Aspergillus fermentation product, and enzyme production promoter | 悠绿那股份有限公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-110582562-A | Aspergillus fermentation product, food composition, cosmetic composition, raw material for Aspergillus fermentation product, process for producing Aspergillus fermentation product, and enzyme production promoter | 悠绿那股份有限公司 | 2019-12-17 | — | — | CN | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070196859-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196859-A1 | Novel antibacterial agents | ENGASE, PEPD, PGLS | ECE1 438/4885MME 186/4885CASP3 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.